ClearPoint Neuro Inc [CLPT] stock is trading at $13.99, down -2.17%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The CLPT shares have lost -16.28% over the last week, with a monthly amount drifted -44.00%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on October 24, 2023, and set its price target to $8. Lake Street initiated its recommendation with a Buy and recommended $32 as its price target on March 18, 2021. B. Riley FBR started tracking with a Buy rating for this stock on July 17, 2020, and assigned it a price target of $8.
ClearPoint Neuro Inc [CLPT] stock has fluctuated between $9.76 and $30.10 over the past year. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. ClearPoint Neuro Inc [NASDAQ: CLPT] shares were valued at $13.99 at the most recent close of the market. An investor can expect a potential return of 28.66% based on the average CLPT price forecast.
Analyzing the CLPT fundamentals
ClearPoint Neuro Inc [NASDAQ:CLPT] reported sales of 34.33M for the trailing twelve months, which represents a growth of 9.10%. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -0.67%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.94 and Total Capital is -0.41. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.55 points at the first support level, and at 13.12 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.43, and for the 2nd resistance point, it is at 14.88.
Ratios To Look Out For
For context, ClearPoint Neuro Inc’s Current Ratio is 6.37. Further, the Quick Ratio stands at 5.56, while the Cash Ratio is 5.62. Considering the valuation of this stock, the price to sales ratio is 11.58, the price to book ratio is 25.05.
Transactions by insiders
Recent insider trading involved PTC Therapeutics, Inc., Affiliate of director, that happened on Nov 12 ’25 when 0.89 million shares were purchased. CEO and President, BURNETT JOSEPH completed a deal on Oct 10 ’25 to sell 26463.0 shares. Meanwhile, Affiliate of Director JOSEPH M BURNETT TRUST bought 26463.0 shares on Oct 10 ’25.
